Davenport & CO LLC Seelos Therapeutics, Inc. Transaction History

Davenport & CO LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	BUY	$0.16 - $1.64 $1,600 - $16,400	10,000 Added 7.38%	145,500 $26,000
Q1 2022 May 02, 2022	SELL	$0.84 - $1.71 $63,000 - $128,250	-75,000 Reduced 35.63%	135,500 $114,000
Q4 2021 Feb 10, 2022	SELL	$1.59 - $2.38 $76,320 - $114,240	-48,000 Reduced 18.57%	210,500 $343,000
Q3 2021 Oct 14, 2021	SELL	$1.69 - $2.89 $25,350 - $43,350	-15,000 Reduced 5.48%	258,500 $623,000
Q2 2021 Jul 28, 2021	BUY	$2.64 - $6.32 $81,840 - $195,920	31,000 Added 12.78%	273,500 $722,000
Q1 2021 Apr 28, 2021	BUY	$1.35 - $4.99 $142,425 - $526,445	105,500 Added 77.01%	242,500 $1.21 Million
Q4 2020 Jan 13, 2021	BUY	$0.74 - $2.01 $101,380 - $275,369	137,000 New	137,000 $216,000
Q3 2020 Oct 15, 2020	SELL	$0.6 - $1.25 $12,000 - $25,000	-20,000 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$0.47 - $1.56 $9,400 - $31,200	20,000 New	20,000 $10,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.